For the first quarter of 2025, MannKind reported net income of $13.2 million, or $0.04 earnings per share - basic, compared to net income of $10.6 million, or $0.04 earnings per share - basic, for the ...

Awaiting FDA action on YUTREPIA™ NDA with a PDUFA goal date of May 24, 2025District Court dismissed cross claim filed by United Therapeutics challenging PH-ILD amendmentFully enrolled Cohort A of ...